Show simple item record

dc.contributor.authorAsamblea Mundial de la Salud, 49
dc.date.accessioned2015-12-29T21:50:35Z
dc.date.available2015-12-29T21:50:35Z
dc.date.issued1996
dc.identifier.govdocWHA49.14
dc.identifier.urihttp://www.who.int/iris/handle/10665/203944
dc.description(‎Punto 17 del orden del día)‎en_US
dc.language.isoesen_US
dc.publisherOrganización Mundial de la Saluden_US
dc.subjectResolutions and decisionsen_US
dc.subjectPharmaceutical productsen_US
dc.subject.meshPharmaceutical Preparationsen_US
dc.subject.meshQuality Controlen_US
dc.subject.meshDrugs, Essentialen_US
dc.subject.meshDrug Delivery Systemsen_US
dc.subject.meshDrug Industryen_US
dc.titleEstrategia revisada en materia de medicamentosen_US
dc.typeGoverning body documentsen_US
dc.subject.meshqualifierstandardsen_US


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record